Catalyst Funds Management Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History
Catalyst Funds Management Pty LTD
- $409 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,488Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.72 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.11 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.11 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.5 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.43 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $77.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...